RNA
Avidity Biosciences Inc Earnings
$44.33
Earnings Summary
Revenue | $3.85Mn |
Net Profits | $-157.32Mn |
Net Profit Margins | -4089.29% |
Avidity Biosciences Inc’s revenue jumped 88.12% since last year same period to $3.85Mn in the Q2 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated 144.56% jump in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -122.22% since last year same period to $-157.32Mn in the Q2 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated -35.88% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin fell -18.13% since last year same period to -4089.29% in the Q2 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated 44.44% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.12 |
EPS Estimate Current Year | -1.12 |
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.12 - a -17.13% fall from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.12.
Key Ratios
Earning Per Share (EPS) | 0 |
Avidity Biosciences Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Avidity Biosciences Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-11 | -1.12 | 0 | 100% |
2025-05-08 | -0.88 | -0.9 | -2.24% |
2025-08-07 | -0.96 | -1.21 | -26.54% |
